Psychedelic Access News Today

Increasing awareness of mental health issues has not yet been translated into innovative treatments, MEPs heard on Tuesday at the launch of PsyPal, the first EU-funded clinical research project into psychedelic-assisted mental health treatments.

A European consortium of 19 partners has been awarded over €6.5M by the European Union to study psilocybin to treat psychological distress in people with progressive incurable illnesses requiring palliative care.

Mental health is a complex and multifaceted field, encompassing diverse domains such as psychology, neuroscience, psychiatry, sociology, and public health. Mental health challenges are on the rise, posing significant burdens on individuals, families, and societies worldwide. There is an urgent need for innovative approaches and solutions. It becomes crucial to explore the pivotal role of networking researchers in advancing our understanding of mental health-related topics.

Psychedelic-assisted MDMA therapy for PTSD has shown some promise in the West, but plans to export it globally may be premature.

MDMA-assisted PTSD therapy has shown some promise in the West, but plans to export it globally are premature, critics say.

MDMA, magic mushrooms, DMT and acid have all had their day as recreational drugs. Now scientists — and companies — are hopeful these could be the game-changing medicines needed for mental health disorders.